In response to Chuong et al
- PMID: 39252883
- PMCID: PMC11381994
- DOI: 10.1016/j.ctro.2024.100839
In response to Chuong et al
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Kharofa J., Mierzwa M., Olowokure O., Sussman J., Latif T., Gupta A., et al. Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancer. Am J Clin Oncol. 2019;42(3):247–252. doi: 10.1097/COC.0000000000000518. - DOI - PubMed
-
- Zhu X., Ju X., Cao Y., Shen Y., Cao F., Qing S., et al. Patterns of local failure after stereotactic body radiation therapy and sequential chemotherapy as initial treatment for pancreatic cancer: Implications of target volume design. Int J Radiat Oncol Biol Phys. 2019;104(1):101–110. doi: 10.1016/j.ijrobp.2019.01.075. - DOI - PubMed
-
- Chuong M.D., Bryant J., Mittauer K.E., Hall M., Kotecha R., Alvarez D., et al. Ablative 5-fraction stereotactic magnetic resonance–guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer. Pract Radiat Oncol. 2021;11(2):134–147. doi: 10.1016/j.prro.2020.09.005. - DOI - PubMed
LinkOut - more resources
Full Text Sources
